Cenos Therapeutics
PrivateCompany Overview
Cenos Therapeutics is a biotechnology company developing a blood-brain barrier shuttle platform for the treatment of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
blood-brain barrier shuttleRNA therapeuticsdeep brain deliverydrug delivery platformneurotherapeuticsconjugate RNAblood-brain barrierBBBcentral nervous systemCNSneurological diseasessystemic deliverydrug discoverypreclinical biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cenos Therapeutics Comparables
Compare Cenos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aerska | 86% | |
| Ossianix | 81% | |
| Iris Medicine | 81% | |
Cenos Therapeutics Funding Rounds
Historical fundraising activity
Cenos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cenos Therapeutics's valuation, stock price, and market status.